SCHEMBL4211136

SCHEMBL4211136

O=C(O)c1ccc(CCc2ccccc2)cc1Nc1ccccc1C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.54
AKR1C2 P52895 2/20 0.54
GAA P10253 2/20 0.53
POLB P06746 1/20 0.53
TAS2R14 Q9NYV8 8/20 0.52
FABP4 P15090 1/20 0.51
GRIK1 P39086 1/20 0.51
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 1/20 0.45
CLCN2 P51788 1/20 0.43
EPHX2 P34913 1/20 0.43
AKR1B10 O60218 1/20 0.43
AKR1B1 P15121 1/20 0.43
AKR1C4 P17516 1/20 0.43
AKR1C1 Q04828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4221179 0.85 POLB (0.46) AKR1C3AKR1C2GAAPOLBTAS2R14
SCHEMBL4219603 0.83 MEN1 (0.51) AKR1C3AKR1C2FABP4GRIK1KMT2A
SCHEMBL2276347 0.82 MEN1 (0.56) GAAPOLBTAS2R14GRIK1KMT2A
SCHEMBL4226633 0.82 CLCN2 (0.52) AKR1C3AKR1C2GAAKMT2AMEN1
SCHEMBL4212766 0.81 AKR1C3 (0.48) AKR1C3AKR1C2GAATAS2R14KMT2A
SCHEMBL4215640 0.81 MEN1 (0.52) AKR1C3AKR1C2FABP4GRIK1KMT2A
SCHEMBL4220677 0.81 MEN1 (0.56) AKR1C3AKR1C2TAS2R14GRIK1KMT2A
SCHEMBL1358523 0.80 TAS2R14 (0.75) AKR1C3AKR1C2TAS2R14FABP4GRIK1
SCHEMBL4221452 0.80 TDP1 (0.51) AKR1C3AKR1C2GAAFABP4KMT2A
SCHEMBL4217206 0.80 MEN1 (0.61) AKR1C3AKR1C2FABP4GRIK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 AKR1C3 105/4885AKR1C2 287/4885GAA 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.